Endoplasmic reticulum stress-induced resistance to doxorubicin is reversed by paeonol treatment in human hepatocellular carcinoma cells.
Endoplasmic reticulum stress-induced resistance to doxorubicin is reversed by paeonol treatment in human hepatocellular carcinoma cells.
复制标题
在人肝细胞癌细胞中,丹皮酚处理可逆转内质网应激诱导的多柔比星耐药性。
DOI:
10.1371/journal.pone.0062627
复制
发表时间:
2013
期刊:
影响因子:
3.7
通讯作者:
Wei W
中科院分区:
文献类型:
--
作者:
Fan L;Song B;Sun G;Ma T;Zhong F;Wei W
Endoplasmic reticulum stress (ER stress) is generally activated in solid tumors and results in tumor cell anti-apoptosis and drug resistance. Paeonol (Pae, 2-hydroxy-4-methoxyacetophenone), is a natural product extracted from the root of Paeonia Suffruticosa Andrew. Although Pae displays anti-neoplastic activity and increases the efficacy of chemotherapeutic drugs in various cell lines and in animal models, studies related to the effect of Pae on ER stress–induced resistance to chemotherapeutic agents in hepatocellular carcinoma (HCC) are poorly understood. In this study, we investigated the effect of the endoplasmic reticulum (ER) stress response during resistance of human hepatocellular carcinoma cells to doxorubicin. Treatment with the ER stress-inducer tunicamycin (TM) before the addition of doxorubicin reduced the rate of apoptosis induced by doxorubicin. Interestingly, co-pretreatment with tunicamycin and Pae significantly increased apoptosis induced by doxorubicin. Furthermore, induction of ER stress resulted in increasing expression of COX-2 concomitant with inactivation of Akt and up-regulation of the pro-apoptotic transcription factor CHOP (GADD153) in HepG2 cells. These cellular changes in gene expression and Akt activation may be an important resistance mechanism against doxorubicin in hepatocellular carcinoma cells undergoing ER stress. However, co-pretreatment with tunicamycin and Pae decreased the expression of COX-2 and levels of activation of Akt as well as increasing the levels of CHOP in HCC cells. Our results demonstrate that Pae reverses ER stress–induced resistance to doxorubicin in human hepatocellular carcinoma cells by targeting COX-2 mediated inactivation of PI3K/AKT/CHOP.
登录
查看更多内容
影响因子:
5.1
作者:
Kapoor, Ashwani;Sanyal, Arun J.
通讯作者:
Sanyal, Arun J.
影响因子:
3.7
作者:
Lee HJ;Kim SA;Lee HJ;Jeong SJ;Han I;Jung JH;Lee EO;Zhu S;Chen CY;Kim SH
通讯作者:
Kim SH
影响因子:
29.4
作者:
Diehl JA;Fuchs SY;Koumenis C
通讯作者:
Koumenis C
DOI:
10.1083/jcb.201003138
发表时间:
2010-05-31
期刊:
The Journal of cell biology
影响因子:
--
作者:
Rutkowski DT;Hegde RS
通讯作者:
Hegde RS
影响因子:
3.7
作者:
Catalano, Rob D.;Wilson, Martin R.;Jabbour, Henry N.
通讯作者:
Jabbour, Henry N.